Literature DB >> 25218622

Rıvaroxaban-induced severe diffuse ıntracerebral hemorrhage.

Fatih Çalışkan1, Hızır Ufuk Akdemir2, Hakan Nurata3, Neslihan Akdemir4, Gökhan Başara5, Yücel Yavuz1.   

Abstract

Bleeding, the most frightening adverse effect of anticoagulants,may occur in different parts of the body.When intracerebral hemorrhage in individuals used anticoagulant drugs is compared with normal coagulation function, the volume of bleeding is increased and the prognosis is worse. There are few studies in the literature regarding the presence of intracerebral hemorrhage and the volume and prognosis of bleeding associated with rivaroxaban, a new oral anticoagulant.Therefore, the clinical and radiologic findings and follow-up of an 80-year-old male patient with intracerebral hemorrhage who uses rivaroxaban for anticoagulation are presented in this article.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25218622     DOI: 10.1016/j.ajem.2014.08.028

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

1.  Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.

Authors:  Luca Monaco; Chiara Biagi; Valentino Conti; Mauro Melis; Monia Donati; Mauro Venegoni; Alberto Vaccheri; Domenico Motola
Journal:  Br J Clin Pharmacol       Date:  2017-03-19       Impact factor: 4.335

2.  Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study.

Authors:  Anne-Laure Sennesael; Anne-Sophie Larock; Bérangère Devalet; Valérie Mathieux; Franck Verschuren; Xavier Muschart; Olivia Dalleur; Jean-Michel Dogné; Anne Spinewine
Journal:  Br J Clin Pharmacol       Date:  2018-04-17       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.